Chrysafios Girasis

A New Tool for the Risk Stratification of Patients With Complex Coronary Artery Disease

Scot Garg, Giovanna Sarno, Héctor M. García‐García et al. · Circulation Cardiovascular Interventions · 2010 · 259 citations · Full text

Medicine, Cardiology, Clinical Classification Systems +16

Value of the SYNTAX Score for Risk Assessment in the All-Comers Population of the Randomized Multicenter LEADERS (Limus Eluted from A Durable versus ERodable Stent coating) Trial

Joanna J. Wykrzykowska, Scot Garg, Chrysafios Girasis et al. · Journal of the American College of Cardiology · 2010 · 220 citations

Pharmacy, Risk Management, Risk Assessment +9

SYNTAX score and Clinical SYNTAX score as predictors of very long-term clinical outcomes in patients undergoing percutaneous coronary interventions: a substudy of SIRolimus-eluting stent compared with pacliTAXel-eluting stent for coronary revascularization (SIRTAX) trial

Chrysafios Girasis, Scot Garg, Lorenz Räber et al. · European Heart Journal · 2011 · 158 citations · Full text

Medicine, Cardiology, Clinical Sciences +16

Circumferential evaluation of the neointima by optical coherence tomography after ABSORB bioresorbable vascular scaffold implantation: Can the scaffold cap the plaque?

Salvatore Brugaletta, Maria Radu, Héctor M. García‐García et al. · Atherosclerosis · 2011 · 131 citations

Engineering, Bioengineering, Biomedical Engineering +12

A Global Risk Approach to Identify Patients With Left Main or 3-Vessel Disease Who Could Safely and Efficaciously Be Treated With Percutaneous Coronary Intervention

Patrick W. Serruys, Vasim Farooq, Pascal Vranckx et al. · JACC: Cardiovascular Interventions · 2012 · 97 citations

Medicine, Cardiology, Surgery +16